A new study has found that the treatment of hematurias is a better option than other treatment options for patients with cancer treatment.
The study was conducted by Dr M.D. A. O’Donnell of the Medical Research Council, the charity that supports the Irish Hematuria Treatment Program.
It found that patients with hematuriae have a significantly lower chance of dying of cancer, and are much less likely to experience the side effects of chemotherapy and radiotherapy, which can cause serious side effects.
Dr O’Neill said the study was a positive step forward for hematurian patients.
“They are actually more likely to survive,” he said.
“It is a very promising study and we are keen to see if this is going to help further the situation for other patients who are not currently on treatment.”
There is also the issue of safety, as well as the benefit of hematotoxic chemotherapy, which may help reduce the risk of side effects.”Dr O